Evaluation of the U.K. 2-week referral rule for skin cancer
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
BACKGROUND: In 1997 the U.K. government introduced the target that all patients seen in primary care, and whose general practitioner suspected a possible diagnosis of any cancer, would be seen by a specialist within 2 weeks. Several individual departmental reports suggest that this has generated a high volume of 'urgent' referrals and has been unachievable without impact on other patients. OBJECTIVES: To determine the views of dermatologists, with audit and database information where possible, on the overall impact of the 2-week rule referral standard for suspected skin cancers. METHODS: A questionnaire was sent to consultant dermatologists in the U.K. requesting views and numerical data. RESULTS: There were 139 responses, some on a departmental basis, representing 272 individuals (nearly two-thirds of all consultant dermatologists in post in the U.K). Based on 52 formal audit studies or database information, the overall proportion of confirmed skin cancers among 2-week rule referrals was 12%, but only 42% of tumours were referred by this route. Correct suspicion of melanoma was generally better than that of squamous cell carcinoma. Information on standard referral proformas was only considered to be 'usually adequate' by 34% of departments. Considering all replies, only 27% of respondents felt that the 2-week rule works well; the major problems are an excess of benign lesions, the lack of opportunity to prioritize referrals and the displacement of other urgent problems. CONCLUSIONS: There are significant problems with the perception and application of the 2-week referral standard for possible skin cancers, including a high volume of nonrelevant lesions and displacement of other urgent conditions. Increasing the specificity of referral guidelines, and increased education regarding recognition of benign lesions, are the favoured options for improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HEALSMITH, M. F., BOURKE, J. F., OSBORNE, J. E., & GRAHAM-BROWN, R. A. C. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb06881.x · Cited by 124
Research works printed but not linked: 22
- 10.1046/j.1365-2133.1999.03111.x · DOI
- 10.1046/j.1365-2133.2000.03354.x · doi:10.1046/j.1365-2133.2000.03354.x
- 10.1046/j.1365-2133.2000.03346.x · DOI
- Shum KW, 2002, Br J Dermatol, 147, 2
- 10.1046/j.1365-2133.2002.04814_1.x · doi:10.1046/j.1365-2133.2002.04814_1.x
- Naryan S, 2002, Br J Dermatol, 147, 47
- 10.1046/j.1365-2133.2002.04919.x · doi:10.1046/j.1365-2133.2002.04919.x
- Pearson IC, 2002, Br J Dermatol, 147, 44
- Thomson MA, 2003, Br J Dermatol, 149, 28
- Leslie KS, 2003, Br J Dermatol, 149, 29, 10.1046/j.0366-077X.2003.05688.x · doi:10.1046/j.0366-077x.2003.05688.x
- Hashim N, 2003, Br J Dermatol, 149, 33
- Resneck J, 2001, Arch Dermatol, 137, 1295, 10.1001/archderm.137.10.1295 · DOI · Paper page
- Suneja T, 2001, Arch Dermatol, 137, 1307, 10.1001/archderm.137.10.1303 · DOI · Paper page
- 10.1136/bmj.322.7302.1555 · DOI
- 10.1136/gut.48.1.53 · DOI · Paper page
- Morris AD, 2003, Br J Dermatol, 148, 608, 10.1046/j.1365-2133.2003.05209_16.x · doi:10.1046/j.1365-2133.2003.05209_16.x
- MacKie RM, 1989, Malignant Melanoma. A Guide to Early Diagnosis
- 10.1046/j.1365-2133.1999.02823.x · DOI
- 10.1136/bmj.321.7255.236 · doi:10.1136/bmj.321.7255.236
- 10.1054/brst.1999.0151 · doi:10.1054/brst.1999.0151
- Jones R, 2001, Health Service J, 111, 20
- 10.1038/35070647 · DOI
Cited by
Store-and-Forward Teledermatology in Skin Cancer Triage
Moreno-Ramirez, D., Ferrandiz, L., Nieto-Garcia, A., Carrasco, R., Moreno-Alvarez, P., Galdeano, R., Bidegain, E., Rios-Martin, J. J., & Camacho, F. M. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.4.479 · Cited by 163
Telemedicine in dermatology: a randomised controlled trial
Bowns, I., Collins, K., Walters, S., & McDonagh, A. (2006) · Health Technology Assessment · doi:10.3310/hta10430 · Cited by 109
May, C., Giles, L., & Gupta, G. (2008) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2008.02850.x · Cited by 43
Metadata
- Authors
- Cox, N. H.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02
- Volume
- 150
- Issue
- 2
- Pages
- 291-298
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W1969458739
- Cited by
- 49
- References
- 1
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 4230 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evaluation of the U.K. 2-week referral rule for skin cancer. https://app.cochat.ai/papers/10.1111/j.1365-2133.2004.05793.x
- The paper
- Cox, N. H. (2004). Evaluation of the U.K. 2-week referral rule for skin cancer. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2004.05793.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.